Memo Therapeutics
Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.
Total raised
€96M
€95,630,854
Funding rounds
4
Investors
15
distinct backers
Active since
2020-11
latest 2024-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood47
base rate 51% for Series C
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 14y since founding
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-05-07 | Series C | €20M | Kurma Partners,Ysios Capital | View deal → |
| 2023-11-02 | Series C | €26M | Adjuvant Capital,Fresenius Medical Care Ventures,GF Group Holding,Pureos Bioventures,Red Alpine,Schroders Capital+3 more | View deal → |
| 2022-02-16 | Series B | €35M | Adjuvant Capital,Fresenius Medical Care Ventures,GF Group Holding,Swisscanto Invest,Verve Ventures,Vesalius Biocapital Partners+1 more | View deal → |
| 2020-11-06 | Series A | €14M | Redalpine | View deal → |
Investors
15Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy